Molecular Genetics of Familial Renal Cell Carcinoma Syndromes
- 19 April 2005
- journal article
- review article
- Published by Elsevier BV in Clinics in Laboratory Medicine
- Vol. 25 (2), 259-277
- https://doi.org/10.1016/j.cll.2005.01.003
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Genotype-phenotype correlation in von Hippel-Lindau families with renal lesionsHuman Mutation, 2004
- Biallelic Inactivation of Fumarate Hydratase (FH) Occurs in Nonsyndromic Uterine Leiomyomas but Is Rare in Other TumorsThe American Journal of Pathology, 2004
- Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor GrowthPLoS Biology, 2003
- Mutations in the Fumarate Hydratase Gene Cause Hereditary Leiomyomatosis and Renal Cell Cancer in Families in North AmericaAmerican Journal of Human Genetics, 2003
- The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathwayOncogene, 2002
- Coupling Met to Specific Pathways Results in Distinct Developmental OutcomesMolecular Cell, 2001
- Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activityOncogene, 1999
- Familial non-VHL non-papillary clear-cell renal cancerThe Lancet, 1997
- Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.Journal of Medical Genetics, 1990
- Hereditary Renal-Cell Carcinoma Associated with a Chromosomal TranslocationThe New England Journal of Medicine, 1979